Floatz logo

CO-METHYLCOBINAMIDE DIHYDROGEN PHOSPHATE (ESTER) INNER SALT 3'-ESTER WITH 5,6-DIMETHYL-1-.ALPHA.-D-RIBOFURANOSYL-1H-BENZIMIDAZOLE-.KAPPA.N(SIP 3)

Vascular Dementia

Pamlab, Inc.Small moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Vascular Dementia cohort.

Asset / SponsorPhaseRating
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Peking University First Hospital
Phase 4BB
Acetylsalicylic Acid
Peking University First Hospital
Phase 4BB
Rivastigmine
Novartis
Phase 3BB
FLUDEOXYGLUCOSE
Mayo Clinic
Phase 4BB
FLORTAUCIPIR
Mayo Clinic
Phase 4BB

View all 20 →

Same molecule, other indications

CO-METHYLCOBINAMIDE DIHYDROGEN PHOSPHATE (ESTER) INNER SALT 3'-ESTER WITH 5,6-DIMETHYL-1-.ALPHA.-D-RIBOFURANOSYL-1H-BENZIMIDAZOLE-.KAPPA.N(SIP 3) is also rated in:

amyotrophic lateral sclerosisDormant
B
Indicative ·
57 / 100
View asset →
breast cancerDormant
CCC
Indicative ·
54 / 100
View asset →
Postherpetic Neuralgia ( PHN )Dormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →